Skip to content
ZoomBio

Cancer

Supreme Court wants cap on trade margin for all essential medicines and medical products

Reported by The Hindu ·

Image: The Hindu, via the original article

Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients

Summary as published by The Hindu.

Read the full story

The complete article is on The Hindu's website.